Antimicrobial considerations in the perioperative patient

The Veterinary Clinics of North America. Small Animal Practice
Dawn Merton Boothe, H W Boothe

Abstract

Surgical site infections are among the complications that can be reduced with the timely implementation of appropriate antimicrobial therapy. A 3-D approach to judicious antimicrobial use focuses on the de-escalation of systemic antimicrobial therapy, design of dosing regimens, and decontamination of the surgeon, patient, and environment. De-escalation can be accomplished in part through proper antimicrobial prophylaxis. Dosing regimens should be designed to maximize efficacy and minimize resistance. Decontamination includes disinfection of inanimate surfaces and timely application of appropriate antiseptics at concentrations that maximize efficacy.

References

Feb 24, 2001·AORN Journal·E L LarsonP Della-Latta
Jun 5, 2001·The Journal of Antimicrobial Chemotherapy·D NeutH J Busscher
Jan 16, 2002·American Journal of Respiratory and Critical Care Medicine·Harald HerknerMarkus Müller
Jul 20, 2002·Critical Care Medicine·Christian JoukhadarMarkus Müller
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Markus MüllerHartmut Derendorf
Sep 15, 2004·Veterinary Surgery : VS·Simone EugsterPatrick Boerlin
Oct 19, 2004·Clinical Microbiology Reviews·Günter Kampf, Axel Kramer
Dec 17, 2004·The Journal of Small Animal Practice·M R OwenR J Coe
Mar 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gerald P Bodey
May 27, 2005·Antimicrobial Agents and Chemotherapy·Sandrine MarchandWilliam Couet
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Sandrine MarchandWilliam Couet
Sep 1, 2005·Journal of Clinical Periodontology·P D Marsh
Sep 24, 2005·Journal of the American Veterinary Medical Association·Bianca E HettlichMark Carpenter
Nov 7, 2006·Journal of Veterinary Pharmacology and Therapeutics·M R StegemannS Blanchflower
Feb 6, 2007·Veterinary Microbiology·A L ClutterbuckS L Percival
Apr 28, 2007·Veterinary Surgery : VS·Heidi PhillipsR Avery Bennett
Nov 5, 2008·Journal of the American Animal Hospital Association·Kathleen HamAnn L Johnson
Nov 22, 2008·The Journal of Hospital Infection·C D Owens, K Stoessel
Jan 6, 2009·American Journal of Veterinary Research·D M BootheH W Boothe
Jan 13, 2009·Veterinary Surgery : VS·Chad W SchmiedtJonathan F McAnulty
Feb 28, 2009·Veterinary Microbiology·J Scott Weese, Engeline van Duijkeren
Jul 11, 2009·Biopharmaceutics & Drug Disposition·Chinmay ShuklaGrazia Stagni
Mar 17, 2010·The Journal of Antimicrobial Chemotherapy·Veronika MatziChristian Joukhadar
Aug 14, 2010·Veterinary Surgery : VS·Aylin AtillaDawn M Boothe
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·S M McHughH Humphreys
Mar 29, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Johan W MoutonJohn Turnidge
May 19, 2011·Annals of Surgery·J Wesley AlexanderMichael J Edwards
Nov 8, 2011·Journal of the American Animal Hospital Association·Steven A NeihausRobert L Goring
Nov 19, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·G BonkatA F Widmer
Jan 19, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dale W BratzlerUNKNOWN Society for Healthcare Epidemiology of America
May 7, 2013·BMC Veterinary Research·Ameet SinghJeffrey Scott Weese
May 25, 2013·The Veterinary Journal·M LawrenceS Narayanan
Sep 10, 2014·Veterinary Surgery : VS·Ryen TurkJ Scott Weese
Sep 10, 2014·Veterinary Surgery : VS·Alim NazaraliJ Scott Weese
Sep 26, 2014·Current Opinion in Pharmacology·Gian Maria RossoliniSimona Pollini

❮ Previous
Next ❯

Citations

Feb 13, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Safy HadiyaSherine A Aly
Dec 20, 2018·Frontiers in Veterinary Science·Bárbara Gómez-Poveda, Miguel A Moreno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale
John M Conly
The Veterinary Clinics of North America. Small Animal Practice
H W Boothe
The Practitioner
L P GARROD
Surgery, Gynecology & Obstetrics
T F MEDREK, W LITSKY
© 2022 Meta ULC. All rights reserved